Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

78009

	registered interest
	date	15/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, for what reason none of the £42 million his Department has made available for increasing the use of radiotherapy is to be spent on treating cancer patients with Stereotactic Ablative Radiotherapy this year.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	205834
	answer	answer is ministerial correction date of answer 22/07/2014 answer text <p>In July 2011, the National Radiotherapy Implementation Group concluded that current evidence supports treatment withstereotactic ablative radiotherapy (SABR) for only a small number of patients. The evidence supports its use in the treatment of early stage lung cancers for patients who are unsuitable for surgery (approximately 1,000 per annum).</p><p> </p><p>NHS England recognises the positive clinical impact that its national policy on SABR for the treatment of early non-small cell lung cancer has had. It is currently examining the potential use of SABR in patients with oligometastatic disease – where a cancer is in the early stages of spreading.</p><p> </p><p>NHS England is also currently undertaking a review of stereotactic radiosurgery (SRS) and SABR for intracranial conditions to establish what the national demand is in line with its national clinical commissioning policies on SRS and SABR, and what the national capacity requirements are for this specialised treatment. Following the review it is planned that a final decision will be taken by the Specialised Commissioning Oversight Group in October 2014.</p><p> </p><p>Later this year, the Radiotherapy Clinical Reference Group will review its current policy position on SABR to assess whether there is new evidence to recommend its use on other conditions. It is important to ensure that treatments commissioned are supported by robust evidence of their benefit to patients.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 22/07/2014 13:47:28 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

78013

	registered interest
	date	15/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many individual funding requests per indication were received by NHS England for radiotherapy treatment in the last financial year; and how many requests, per indication, were refused by NHS England.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	205953
	answer	answer is ministerial correction date of answer 21/07/2014 answer text <p>Since April 2013, radiotherapy treatment has been planned and paid for nationally by NHS England.</p><p> </p><p>NHS England has informed us that information on the number of individual funding requests made to NHS England is not currently available. NHS England is improving its data collection mechanisms and aims to improve availability of such information in the future.</p><p><br><br></p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 21/07/2014 16:41:28 answering member 1439 label Biography information for Norman Lamb
	tabling member	4089 label Biography information for Tessa Munt

61873

	registered interest
	date	13/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, pursuant to the Answer of 9 June 2014, Official Report, column 61W, on radiotherapy, what reports he has received of the reasons NHS England has paid for gamma knife treatment at University College Hospital London for a patient referred there from Plymouth Derriford Hospital by James Palmer, NHS England's Clinical Director of Specialised Commissioning.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	200731
	answer	answer is ministerial correction date of answer 23/06/2014 answer text <p>For reasons of patient confidentiality, it is not possible to comment explicitly on either case referred to. However, any primary care trust authorisations made for the gamma knife prior to 1 April 2013 were honoured by NHS England and the invoice associated with the agreed work was paid. University College London Hospitals (UCLH) were required to forward any referrals made after 1 April 2013 to NHS England, along the prescribed pathway, in accordance with the contract between the two. No invoices for work carried out by Queen's Square Radiotherapy Centre at its own risk on behalf of UCLH have been paid by NHS England for referrals after 1 April 2013.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 200728 question first answered 23/06/2014 15:44:40 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

61875

	registered interest
	date	13/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the Answer of 24 March 2014, Official Report, column 132W, on radiotherapy, what reports he has received on the reasons NHS England has paid for Gamma Knife treatment at University College Hospital London (UCHL) for a patient with an acoustic neuroma referred to UCHL from Bournemouth and Poole Hospital.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	200728
	answer	answer is ministerial correction date of answer 23/06/2014 answer text <p>For reasons of patient confidentiality, it is not possible to comment explicitly on either case referred to. However, any primary care trust authorisations made for the gamma knife prior to 1 April 2013 were honoured by NHS England and the invoice associated with the agreed work was paid. University College London Hospitals (UCLH) were required to forward any referrals made after 1 April 2013 to NHS England, along the prescribed pathway, in accordance with the contract between the two. No invoices for work carried out by Queen's Square Radiotherapy Centre at its own risk on behalf of UCLH have been paid by NHS England for referrals after 1 April 2013.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 200731 question first answered 23/06/2014 15:44:40 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

78005

	registered interest
	date	15/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will request NHS England to authorise the use of Gamma Knife for NHS patients at University College Hospital London.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	206028
	answer	answer is ministerial correction date of answer 21/07/2014 answer text <p>NHS England is an independent arm’s length body and since 1 April 2013, it has been responsible for commissioning all radiotherapy services, including stereotactic radiosurgery. Gamma Knife treatment has been available to all patients who meet clinical criteria, without the need for individual funding requests, under NHS England’s national clinical commissioning policies for specialised services.</p><p> </p><p>University College London Hospitals is not contracted by NHS England, nor was it contracted by former primary care trusts, to provide Gamma Knife services. It is for this reason that National Health Service patients cannot normally be treated at this facility. Instead, NHS patients requiring Gamma Knife treatment should be treated by the Gamma Knife services commissioned by the NHS, that have been shown to meet NHS England service specifications. These can be accessed by patients in London without a waiting time, fully maintaining the continuity of their care and normally with the same consultant and clinical team.</p><p> </p><p>All patients need to be treated in accordance with the prescribed clinical pathways and in line with contractual agreements with providers.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 205954 question first answered 21/07/2014 16:30:36 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

78016

	registered interest
	date	15/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, for what reasons NHS England is instructing hospitals with patients presenting as clinically urgent to treat such patients with innovative radiotherapy at the hospital's financial risk while it decides whether to fund the patient; and how hospitals which have followed that instruction receive reimbursement for that expenditure if NHS England subsequently refuses to fund the treatment.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	205954
	answer	answer is ministerial correction date of answer 21/07/2014 answer text <p>NHS England is an independent arm’s length body and since 1 April 2013, it has been responsible for commissioning all radiotherapy services, including stereotactic radiosurgery. Gamma Knife treatment has been available to all patients who meet clinical criteria, without the need for individual funding requests, under NHS England’s national clinical commissioning policies for specialised services.</p><p> </p><p>University College London Hospitals is not contracted by NHS England, nor was it contracted by former primary care trusts, to provide Gamma Knife services. It is for this reason that National Health Service patients cannot normally be treated at this facility. Instead, NHS patients requiring Gamma Knife treatment should be treated by the Gamma Knife services commissioned by the NHS, that have been shown to meet NHS England service specifications. These can be accessed by patients in London without a waiting time, fully maintaining the continuity of their care and normally with the same consultant and clinical team.</p><p> </p><p>All patients need to be treated in accordance with the prescribed clinical pathways and in line with contractual agreements with providers.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 206028 question first answered 21/07/2014 16:30:36 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt